A new randomized crossover study published in Nature Medicine on June 15, 2026, shows that adaptive deep brain stimulation is feasible and safe for dynamic gait control in Parkinson's disease patients.[1111563][1111565] The therapy reduces falls compared to continuous stimulation in Parkinson's disease patients and improves locomotor deficits with activity-dependent algorithms.[1111563][1111565] According to the study, neural decoding algorithms that leverage physiological principles of locomotor encoding support activity-dependent deep brain stimulation therapies.[1111565] The study's findings were published online in Nature Medicine on June 15, 2026, and have sparked interest in the medical community.[1111563]